Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medtronic Magnetic Resonance (MR) Conditional Tachyarrhythmia Therapy Products Post-approval Study

NCT02849769 is registered in ClinicalTrials.gov with Medtronic as lead sponsor.

NCT NCT02849769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02849769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medtronic Magnetic Resonance (MR) Conditional Tachyarrhythmia Therapy Products Post-approval Study
Lead sponsor
Medtronic
Phase
Observational
Overall status
Completed
Start date
September 30, 2015
Completion date
May 31, 2019
Enrollment
10,979 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tachyarrhythmia